PROMETH VC W Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Prometh Vc W, and what generic alternatives are available?
Prometh Vc W is a drug marketed by Nostrum Labs Inc and is included in one NDA.
The generic ingredient in PROMETH VC W is codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROMETH VC W?
- What are the global sales for PROMETH VC W?
- What is Average Wholesale Price for PROMETH VC W?
Summary for PROMETH VC W
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | PROMETH VC W at DailyMed |
US Patents and Regulatory Information for PROMETH VC W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nostrum Labs Inc | PROMETH VC W/ CODEINE | codeine phosphate; phenylephrine hydrochloride; promethazine hydrochloride | SYRUP;ORAL | 088764-001 | Oct 31, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
